These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26365543)

  • 1. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
    Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
    Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
    Lencioni R; Crocetti L; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of hepatic malignant tumors with irreversible electroporation: A systematic review and meta-analysis of outcomes.
    Tian G; Zhao Q; Chen F; Jiang T; Wang W
    Oncotarget; 2017 Jan; 8(4):5853-5860. PubMed ID: 28009979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and hematologic changes after percutaneous radiofrequency ablation of liver tumors: experience in 83 procedures.
    Cizginer S; Tatli S; Hurwitz S; Tuncali K; vanSonnenberg E; Silverman SG
    J Vasc Interv Radiol; 2011 Apr; 22(4):471-8. PubMed ID: 21463756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niche Applications of Irreversible Electroporation.
    Bhatia SS; Arya R; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in liver enzymes after clinical islet transplantation.
    Rafael E; Ryan EA; Paty BW; Oberholzer J; Imes S; Senior P; McDonald C; Lakey JR; Shapiro AM
    Transplantation; 2003 Nov; 76(9):1280-4. PubMed ID: 14627903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver function tests in metastatic uveal melanoma.
    Kaiserman I; Amer R; Pe'er J
    Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function tests: what is the risk?
    Titcomb CP
    J Insur Med; 2003; 35(1):26-35. PubMed ID: 14694823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
    Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SI: Irreversible Electroporation (IRE). Introduction.
    Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):127. PubMed ID: 26365540
    [No Abstract]   [Full Text] [Related]  

  • 19. Study on blood biochemical diagnostic indices for hepatic function biomarkers in endemic skeletal fluorosis.
    Shashi A; Bhardwaj M
    Biol Trace Elem Res; 2011 Nov; 143(2):803-14. PubMed ID: 21243442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures.
    Nair RT; Silverman SG; Tuncali K; Obuchowski NA; vanSonnenberg E; Shankar S
    Radiology; 2008 Jul; 248(1):303-11. PubMed ID: 18566180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.